Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care.
Eur J Health Econ
; 7(1): 72-8, 2006 Mar.
Article
em En
| MEDLINE
| ID: mdl-16429296
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Cilastatina
/
Tienamicinas
/
Dipeptidases
/
Unidades de Terapia Intensiva
/
Antibacterianos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Health_economic_evaluation
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article